On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

USH1G

USH1 protein network component sans

Chromosome 17q25.1 Various HGNC:16356 Tier C
USH1G 17q25.1 p arm q arm 17

USH1G is located on the long (q) arm of chromosome 17, at band 17q25.1. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 17 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

USH1G is located on chromosome 17 and encodes a 461-amino acid scaffold protein called SANS (scaffold protein containing ankyrin repeats and SAM domain). This protein plays an essential role in organising protein networks within sensory hair cells of the inner ear, which convert sound vibrations into electrical signals the brain can interpret. Pathogenic variants in USH1G are associated with severe sensorineural hearing loss, either as an isolated finding or as part of Usher syndrome type 1G, where profound deafness from birth is accompanied by retinal degeneration that typically manifests in childhood. The gene is included in UK clinical genomics panels for monogenic hearing loss and retinal disorders, reflecting its diagnostic importance in evaluating individuals with early-onset sensory impairments.

What the gene does

The SANS protein functions primarily as a molecular scaffold, bringing together multiple proteins into coordinated complexes essential for hair cell structure and signalling. Within the stereocilia-tiny hair-like projections on sensory hair cells-SANS helps establish protein networks that maintain stereociliary organisation and enable mechanotransduction, the process by which mechanical sound vibrations are converted into electrical nerve impulses. The protein's ankyrin repeat domains facilitate protein-protein interactions, allowing SANS to bind and organise other components of the Usher protein network. The SAM domain near the protein's C-terminus mediates additional protein interactions and may contribute to the formation of larger molecular assemblies. Research suggests that SANS is particularly important during the development of cochlear hair cells, where it coordinates the assembly of structures required for normal auditory function. Without functional SANS, these molecular complexes fail to form correctly, leading to impaired hair cell development and progressive degeneration of sensory cells in both the inner ear and, in some cases, the retina.

Video: Genetics 101

Chromosome location

USH1G is located at chromosome 17q25.1, in the long arm of chromosome 17. This chromosomal region contains multiple genes involved in sensory function. The gene comprises several exons that together encode the 461-amino acid SANS protein, though detailed structural annotation of the transcript remains limited in publicly available databases.

Protein structure

The SANS protein contains a distinctive modular architecture with multiple functional regions. The N-terminal portion includes three ankyrin repeats (ANK 1, ANK 2, and ANK 3) spanning amino acids 31-126, which mediate protein-protein interactions characteristic of scaffold proteins. The central region contains two disordered segments (amino acids 208-243 and 332-368) that may provide flexibility for conformational changes during complex assembly. The C-terminal region features a SAM domain (amino acids 385-447), a protein interaction module that enables oligomerisation and binding to other Usher syndrome-associated proteins. This domain organisation reflects SANS's role as a molecular organiser, with multiple binding surfaces available for coordinating protein networks within hair cell stereocilia.

Domain map · 461 amino acids
ANK 1 (31-60)ANK 2 (64-93)ANK 3 (97-126)SAM (385-447)ANK 131-60ANK 264-93SAM385-4471~231461
Repeat - repeating structural motif
Domain - independent functional unit
🧬 Explore 3D structure on AlphaFold
UniProt:Q495M9Length:461 aaStructure:AlphaFold

Key variants

Pathogenic variants in USH1G are relatively rare compared to other hearing loss genes but are clinically significant due to their association with severe congenital deafness. Most disease-causing variants result in loss of protein function through premature stop codons, frameshift changes, or alterations that disrupt critical protein-interaction domains. The specific location and type of variant may influence whether an individual develops isolated hearing loss or the more severe Usher syndrome phenotype with combined auditory and visual impairment.

No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.

Associated conditions

Variants in USH1G are primarily associated with Usher syndrome type 1G, a condition characterised by profound congenital sensorineural deafness, balance difficulties due to vestibular dysfunction, and progressive retinitis pigmentosa beginning in childhood. Some individuals with USH1G variants present with isolated non-syndromic hearing loss without retinal involvement, suggesting genetic or environmental modifiers may influence disease expression. The severity of hearing loss is typically profound from birth, affecting both ears symmetrically. Vision loss in Usher syndrome type 1G generally begins with night blindness in early childhood, followed by progressive constriction of the visual field due to retinal degeneration.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

UK clinical status

Within the NHS Genomic Medicine Service, USH1G is included on the Monogenic hearing loss panel (rated green, version R67) and the Retinal disorders panel (rated green, version R32). Green classification indicates strong evidence supporting the gene-disease relationship and its suitability for diagnostic genomic testing. Individuals presenting with early-onset profound hearing loss, particularly when combined with balance problems or retinal changes, may be eligible for genomic testing that includes USH1G analysis through NHS pathways.

Frequently asked questions

What is the difference between Usher syndrome type 1G and isolated hearing loss caused by USH1G variants?

Both conditions result from pathogenic variants in USH1G, but Usher syndrome type 1G includes progressive vision loss due to retinal degeneration in addition to profound congenital deafness and balance problems. Isolated hearing loss affects only auditory function without retinal involvement, though the reasons some individuals develop the full syndrome while others have hearing loss alone are not fully understood.

How is USH1G-related hearing loss inherited?

USH1G-related conditions follow an autosomal recessive inheritance pattern, meaning an individual must inherit pathogenic variants in both copies of the gene (one from each parent) to develop the condition. Parents who each carry one variant typically have normal hearing and vision themselves.

Can USH1G testing help predict whether someone will develop vision problems?

Identifying pathogenic USH1G variants confirms a genetic cause for hearing loss and indicates risk for retinal degeneration, but genetic testing alone cannot precisely predict the age of onset or severity of vision loss in a specific individual. Regular ophthalmology monitoring is recommended for anyone with confirmed USH1G-related hearing loss to detect early retinal changes.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .